Abstract
Long Term Follow up of a Phase 2 Study of Ruxolitinib in Patients with Splanchnic Vein Thrombosis Associated with Myeloproliferative Neoplasm
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have